Apatinib as Second-line Treatment of Advanced Pancreatic Cancer

NCT02726854 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Apatinib

Sponsor

First Affiliated Hospital Xi'an Jiaotong University